The Supreme People's Court has recently issued a significant and wide-ranging interpretation concerning how the general provisions of the PRC Civil Code should be applied. Diane Peng (Partner), Sijia Li (Counsel) and Aubrey Xiong (Associate) of Fangda Partners analyze the potential impact.

Businesses to receive VAT refunds; plans to improve China's corporate bond market outlined; brand new requirements to develop technology ethically

Multinational corporations with both a U.S. and China presence may increasingly find themselves caught between two legal systems as both countries implement regulations that seek to achieve diametrically opposite objectives. What are the issues and how should companies prepare and respond?

VIE structure is clarified and recognized in human genetic resources projects. Self-examination of medical device production and permit exemption for sale of medical devices are added to revised regulations.

Lawyer service fee rates are required to be filed annually for the record.

An overseas listing may not be allowed for national security reasons.

CSRC permits Chinese firms listing overseas with VIE structure.

The deadline for submissions is June 3, 2022.

Stock clearing agency cuts stock settlement fees, extends support to COVID-hit regions; Three Chinese companies plan to sell depository receipts in Zurich; and MEE slams fraudulent carbon emissions data verification practices